Document 1960 DOCN M94A1960 TI An effective system for tracking challenging populations in community based HIV research. DT 9412 AU Fuentes L; el-Sadr W; Capps L; Harlem Hospital Center, New York, NY 10037. SO Int Conf AIDS. 1994 Aug 7-12;10(1):412 (abstract no. PD0256). Unique Identifier : AIDSLINE ICA10/94370615 AB OBJECTIVES: To describe the various components and analyze the outcomes of a system developed to collect follow-up data on minority patients participating in studies conducted in New York City by the Harlem AIDS Treatment Group. METHODS: A plan for tracking patients was developed by project staff, clinicians, an advisory committee and people living with HIV. The plan included the collection of locator information, building a strong bond between patient and provider, provision of incentives, anticipating missed visits, a contact strategy, networking with city and local resources, and the use of staff that is representative of the community being served. RESULTS: The lost to follow-up rate among 362 patients participating in an Observational Data Base Study decreased from over 70% to 24%. Ongoing efforts continue to improve the collection of data. CONCLUSIONS: The methods employed have facilitated the collection of important HIV data and helped to fortify the bond between patient and provider, a bond which is essential for providing high quality patient care and collecting data in community based research. Challenging populations, minorities and women from lower economic groups, can effectively participate in HIV longitudinal studies. However, specific measures are needed to eliminate or reduce barriers, including patient incentives, the use of personnel representative of the community, and the promotion of strong patient-provider bond. Appropriate resources are needed to conduct such an approach. DE Continuity of Patient Care/*ORGANIZATION & ADMIN Female Follow-Up Studies Human HIV Infections/*THERAPY Longitudinal Studies Male Minority Groups New York City Treatment Refusal Women MEETING ABSTRACT SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).